Status:
UNKNOWN
Traditional Chinese Medicine for Severe COVID-19
Lead Sponsor:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Conditions:
COVID-19
Eligibility:
All Genders
Up to 85 years
Phase:
PHASE3
Brief Summary
In December 2019, a new type of pneumonia, COVID-2019 outbroke in Wuhan ,China, and currently the infected has been reported in more than at least 75 countries. Patients with severe COVID-19 have rap...
Eligibility Criteria
Inclusion
- Key
- Patients were diagnosed as severe COVID-19 according to the Coronavirus disease (COVID-19) Treatment Guidance (Six edition)
- Patients received a combined treatment of TCM and conventional therapy, or only conventional therapy.
- Key
Exclusion
- Age \>85 years
- After cardiopulmonary resuscitation
- Patients combined with other organ failure or conditions need ICU monitoring and treatment, such as severe liver disease, severe renal dysfunction, upper gastrointestinal hemorrhage, disseminated intravascular coagulation.
- Respiratory failure and need mechanical ventilation
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04323332
Start Date
March 1 2020
End Date
April 1 2020
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hao Li
Beijing, Beijing Municipality, China, 100091